Substance Abuse & Addiction
Top Stories
-
Source:
Physicians Weekly
A study led by Matisyahu Shulman, MD, found that rapid administration of extended-release naltrexone was effective compared with the standard procedure used in the treatment of opioid use disorder.
-
Columbia-led clinical trial addresses important barrier to opioid use disorder treatment.
-
Taking time off from drinking provides an opportunity to reexamine your relationship with alcohol and take note of areas in which drinking may be negatively impacting your life.
-
The findings could eventually result in improving access to this life-saving treatment and help close the gap in care.
Latest News
-
Source:
Psychiatric Times
Dr. Lloyd Sederer provides key insights on what we can do to save more lives from overdose deaths.
-
“The more people who are vocal about their drug use, we, as a society, will become less likely to vilify people for what they do with their bodies," says Dr. Carl Hart.
-
"It is important to know that change takes time. Progress is not always linear; relapses or slips are often a part of the process," says Dr. Aimee Chiligiris.
-
Source:
Wall Street Journal
Dr. Sally Satel reviews Dr. Carl Hart's "“Drug Use for Grown-Ups," in which he asserts “recreational drugs can be used safely to enhance many vital human activities.”
-
"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.
-
“I honestly find that most Americans do not think that cannabis can produce dependence, and so I think that’s the first step, knowing that there’s that potential,” says Margaret Haney, PhD
-
The Substance Abuse and Mental Health Services Administration has awarded $32 million to the American Academy of Addiction Psychiatry to address opioid use disorders and stimulant use disorders.
-
This year’s Eric D. Hadar Distinguished Lecture will take place on November 18th, 2020 with Dr. Dorothy Hatsukami, who will present, “Tobacco Harm Reduction: Controversies and a Path Forward.”
-
“More than any other provider group, primary care providers offer greater potential for expanding access to buprenorphine treatment,” says Dr. Mark Olfson.
-
We are currently dealing with the "triple trouble" of a pandemic, unemployment, and diminished personal and community supports writes Dr. Lloyd Sederer.
Pages